Patents by Inventor Ling Jing

Ling Jing has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220156262
    Abstract: Methods, systems, and apparatus, including computer-readable media, for authentication enhanced data indexing and searching. In some implementations, a search service is configured to receive and process queries from a plurality of different application servers, where each application server has an associated data repository. The search service receives a query associated with a user of a client device. The search service provides the query to a search backend having a search index for the plurality of application servers, where the search index describes contents of each of the respective data repositories of the application servers. Search results are received from the search backend, including search results representing data elements from different data repositories of the different application servers. At least some of the search results are provided as an output of the search service as a response to the query.
    Type: Application
    Filed: November 17, 2020
    Publication date: May 19, 2022
    Inventors: Yanjie Chen, Ling Jing, Haijun Hu
  • Patent number: 9451089
    Abstract: A calling center system and a calling processing method of a calling center system are provided in the disclosure. The calling center system includes: an accessing module, configured to receive a user call; multiple CCB units, wherein each CCB unit is configured to select one agent module for serving the user call from multiple agent modules corresponding to the CCB unit, wherein each agent module of the multiple agent modules is configured to serve a user call; a scheduling module, configured to select, according to capability data of the multiple CCB units, the one or more CCB units from the multiple CCB units to perform the operation of selecting one agent module for serving the user call, and select one agent module from one or more agent modules selected by the one or more CCB units to serve the user call. The disclosure can enhance the reliability of the system.
    Type: Grant
    Filed: February 17, 2012
    Date of Patent: September 20, 2016
    Assignee: ZTE CORPORATION
    Inventors: Jingping Wang, Wenyuan Wang, Ling Jing, Wei Zhang
  • Publication number: 20140126717
    Abstract: A calling center system and a calling processing method of a calling center system are provided in the disclosure. The calling center system includes: an accessing module, configured to receive a user call; multiple CCB units, wherein each CCB unit is configured to select one agent module for serving the user call from multiple agent modules corresponding to the CCB unit, wherein each agent module of the multiple agent modules is configured to serve a user call; a scheduling module, configured to select, according to capability data of the multiple CCB units, the one or more CCB units from the multiple CCB units to perform the operation of selecting one agent module for serving the user call, and select one agent module from one or more agent modules selected by the one or more CCB units to serve the user call. The disclosure can enhance the reliability of the system.
    Type: Application
    Filed: February 17, 2012
    Publication date: May 8, 2014
    Applicant: ZTE CORPORATION
    Inventors: Jingping Wang, Wenyuan Wang, Ling Jing, Wei Zhang
  • Publication number: 20050197299
    Abstract: The present invention relates to peptidomimetic compounds useful as protease inhibitors, particularly as serine protease inhibitors and more particularly as hepatitis C NS3 protease inhibitors; intermediates thereto; their preparation including novel steroselective processes to intermediates. The invention is also directed to pharmaceutical compositions and to methods for using the compounds for inhibiting HCV protease or treating a patient suffering from an HCV infection or physiological condition related to the infection. Also provided are pharmaceutical combinations comprising, in addition to one or more HCV serine protease inhibitors, one or more interferons exhibiting anti-HCV activity and/or one or more compounds having anti HCV activity and a pharmaceutically acceptable carrier, and methods for treating or preventing a HCV infection in a patient using the compositions. The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient.
    Type: Application
    Filed: August 31, 2001
    Publication date: September 8, 2005
    Inventors: Robert Babine, Shu-Hul Chen, Jason Lamar, Nancy Snyder, Xicheng Sun, Mark Tebbe, Frantz Victor, Q. Wang, Yvonne Yip, Ivan Collado, Cristina Garcia-Paredes, Raymond Parker, Ling Jing, Deqi Guo, John Glass